Naotaifang III Protects Against Cerebral Ischemia Injury Through LPS/TLR4 Signaling Pathway in the Microbiota-Gut-Brain Axis

Overview

Journal Drug Des Devel Ther

Specialty Pharmacology

Date 2023 Dec 7

PMID 38058793

Authors

Huifang Nie

Jinwen Ge

Kailin Yang

Zhuli Peng

Haihui Wu

Tong Yang

Zhigang Mei

Affiliations

Soon will be listed here.

Abstract

Background: Ischemic stroke (IS) is a leading cause of mortality worldwide. Naotaifang III is a new Chinese herbal formula to treat IS. Previous studies have shown that and in Naotaifang III were able to regulate the imbalance of intestinal microbiota during cerebral ischemia injury.

Methods: Rats were randomly divided into sham operation group, normal control group, middle cerebral artery occlusion (MCAO) group, intestinal microbiota imbalance MCAO group, Naotaifang III group, and normal bacteria transplantation group, with 15 rats in each group. Then, neurological function scores and cerebral infarction volume were detected; haematoxylin and eosin staining and Golgi silver staining were used to observe morphological changes in brain tissue. Meanwhile, the lipopolysaccharide (LPS) and cerebral cortex interleukin (IL)-1β were detected by enzyme-linked immunosorbent assay (ELISA); the expressions of Toll-like receptor (TLR)-4 and nuclear factor kappa-B (NF-κB) proteins were detected by immunofluorescence and Western blot. The cecal flora was detected by 16S rDNA. The results showed that gut dysbiosis aggravated cerebral ischemic injury and significantly increased the expression of LPS, TLR4, NF-κB, and IL-1β, which could be significantly reversed by Naotaifang III or normal bacterial transplantation. Naotaifang III may exert a protective effect on neuroinflammatory injury after MCAO through the LPS/TLR4 signaling pathway in the microbe-gut-brain axis. In summary, Naotaifang III may induce anti-neuroinflammatory molecular mechanisms and signaling pathways through the microbe-gut-brain axis.

Results: The results showed that gut dysbiosis aggravated cerebral ischemic injury and significantly increased the expression of LPS, TLR4, NF-κB, and IL-1β, which could be significantly reversed by Naotaifang III or normal bacterial transplantation. Naotaifang III may exert a protective effect on neuroinflammatory injury after MCAO through the LPS/TLR4 signaling pathway in the microbe-gut-brain axis.

Conclusion: Naotaifang III may induce anti-neuroinflammatory molecular mechanisms and signaling pathways through the microbe-gut-brain axis.

Citing Articles

Gut microbial dysbiosis exacerbates long-term cognitive impairments by promoting intestinal dysfunction and neuroinflammation following neonatal hypoxia-ischemia.

Chen A, Teng C, Wei J, Wu X, Zhang H, Chen P Gut Microbes. 2025; 17(1):2471015.

PMID: 40008452 PMC: 11866968. DOI: 10.1080/19490976.2025.2471015.

Novel Insight into the Modulatory Effect of Traditional Chinese Medicine on Cerebral Ischemia-Reperfusion Injury by Targeting Gut Microbiota: A Review.

Ren Y, Chen G, Hong Y, Wang Q, Lan B, Huang Z Drug Des Devel Ther. 2025; 19():185-200.

PMID: 39810832 PMC: 11731027. DOI: 10.2147/DDDT.S500505.

Advancements in the mechanisms of Naotai formula in treating stroke: A multi-target strategy.

Shi Y, Ma Y, Liao J Heliyon. 2024; 10(17):e36748.

PMID: 39296232 PMC: 11408019. DOI: 10.1016/j.heliyon.2024.e36748.

References

Kurita N, Yamashiro K, Kuroki T, Tanaka R, Urabe T, Ueno Y . Metabolic endotoxemia promotes neuroinflammation after focal cerebral ischemia. J Cereb Blood Flow Metab. 2020; 40(12):2505-2520. PMC: 7820690. DOI: 10.1177/0271678X19899577. View

Andresen L, Theodorou K, Grunewald S, Czech-Zechmeister B, Konnecke B, Luhder F . Evaluation of the Therapeutic Potential of Anti-TLR4-Antibody MTS510 in Experimental Stroke and Significance of Different Routes of Application. PLoS One. 2016; 11(2):e0148428. PMC: 4746129. DOI: 10.1371/journal.pone.0148428. View

Yang X, Li Y, Zhang H, Zhao Y, Ding Z, Yu J . Safflower Yellow regulates microglial polarization and inhibits inflammatory response in LPS-stimulated Bv2 cells. Int J Immunopathol Pharmacol. 2015; 29(1):54-64. PMC: 5806736. DOI: 10.1177/0394632015617065. View

Yang T, Santisteban M, Rodriguez V, Li E, Ahmari N, Carvajal J . Gut dysbiosis is linked to hypertension. Hypertension. 2015; 65(6):1331-40. PMC: 4433416. DOI: 10.1161/HYPERTENSIONAHA.115.05315. View

Yang T, Chen X, Mei Z, Liu X, Feng Z, Liao J . An Integrated Analysis of Network Pharmacology and Experimental Validation to Reveal the Mechanism of Chinese Medicine Formula Naotaifang in Treating Cerebral Ischemia-Reperfusion Injury. Drug Des Devel Ther. 2021; 15:3783-3808. PMC: 8434864. DOI: 10.2147/DDDT.S328837. View

Nicholson S, Watts L, Burmeister D, Merrill D, Scroggins S, Zou Y . Moderate Traumatic Brain Injury Alters the Gastrointestinal Microbiome in a Time-Dependent Manner. Shock. 2018; 52(2):240-248. DOI: 10.1097/SHK.0000000000001211. View

Yamashita T, Emoto T, Sasaki N, Hirata K . Gut Microbiota and Coronary Artery Disease. Int Heart J. 2016; 57(6):663-671. DOI: 10.1536/ihj.16-414. View

Xu K, Gao X, Xia G, Chen M, Zeng N, Wang S . Rapid gut dysbiosis induced by stroke exacerbates brain infarction in turn. Gut. 2021; . DOI: 10.1136/gutjnl-2020-323263. View

Spychala M, Venna V, Jandzinski M, Doran S, Durgan D, Ganesh B . Age-related changes in the gut microbiota influence systemic inflammation and stroke outcome. Ann Neurol. 2018; 84(1):23-36. PMC: 6119509. DOI: 10.1002/ana.25250. View

10.

Chen R, Wu P, Cai Z, Fang Y, Zhou H, Lasanajak Y . Puerariae Lobatae Radix with chuanxiong Rhizoma for treatment of cerebral ischemic stroke by remodeling gut microbiota to regulate the brain-gut barriers. J Nutr Biochem. 2019; 65:101-114. DOI: 10.1016/j.jnutbio.2018.12.004. View

11.

Zhao Y, Wang H, Chen W, Chen L, Liu D, Wang X . Melatonin attenuates white matter damage after focal brain ischemia in rats by regulating the TLR4/NF-κB pathway. Brain Res Bull. 2019; 150:168-178. DOI: 10.1016/j.brainresbull.2019.05.019. View

12.

Yao X, Liu S, Ding W, Yue P, Jiang Q, Zhao M . TLR4 signal ablation attenuated neurological deficits by regulating microglial M1/M2 phenotype after traumatic brain injury in mice. J Neuroimmunol. 2017; 310:38-45. DOI: 10.1016/j.jneuroim.2017.06.006. View

13.

Lan B, Ge J, Cheng S, Zheng X, Liao J, He C . Extract of Naotaifang, a compound Chinese herbal medicine, protects neuron ferroptosis induced by acute cerebral ischemia in rats. J Integr Med. 2020; 18(4):344-350. DOI: 10.1016/j.joim.2020.01.008. View

14.

Durgan D, Lee J, McCullough L, Bryan Jr R . Examining the Role of the Microbiota-Gut-Brain Axis in Stroke. Stroke. 2019; 50(8):2270-2277. PMC: 6646086. DOI: 10.1161/STROKEAHA.119.025140. View

15.

Hu J, Wang W, Hao Q, Zhang T, Yin H, Wang M . Suppressors of cytokine signalling (SOCS)-1 inhibits neuroinflammation by regulating ROS and TLR4 in BV2 cells. Inflamm Res. 2019; 69(1):27-39. DOI: 10.1007/s00011-019-01289-x. View

16.

Longa E, Weinstein P, Carlson S, Cummins R . Reversible middle cerebral artery occlusion without craniectomy in rats. Stroke. 1989; 20(1):84-91. DOI: 10.1161/01.str.20.1.84. View

17.

Zhou Y, Yan S, Song X, Gong Y, Li W, Wang M . Intravenous thrombolytic therapy for acute ischemic stroke in Hubei, China: a survey of thrombolysis rate and barriers. BMC Neurol. 2019; 19(1):202. PMC: 6704516. DOI: 10.1186/s12883-019-1418-z. View

18.

Duran-Laforet V, Pena-Martinez C, Garcia-Culebras A, Cuartero M, Lo E, Moro M . Role of TLR4 in Neutrophil Dynamics and Functions: Contribution to Stroke Pathophysiology. Front Immunol. 2021; 12:757872. PMC: 8566541. DOI: 10.3389/fimmu.2021.757872. View

19.

Li J, Zhao F, Wang Y, Chen J, Tao J, Tian G . Gut microbiota dysbiosis contributes to the development of hypertension. Microbiome. 2017; 5(1):14. PMC: 5286796. DOI: 10.1186/s40168-016-0222-x. View

20.

Singh V, Sadler R, Heindl S, Llovera G, Roth S, Benakis C . The gut microbiome primes a cerebroprotective immune response after stroke. J Cereb Blood Flow Metab. 2018; 38(8):1293-1298. PMC: 6092773. DOI: 10.1177/0271678X18780130. View